射频消融治疗肾癌现状

The present status of percutaneous radiofrequency ablation in renal cell carcinomas

近年来射频消融日益广泛应用于肾癌治疗,随着操作技术的不断发展,已在临床上取得显著的近期疗效,具有微创、安全、操作方便、并发症轻、患者痛苦少等特点。其未来发展的关键在于改进电极针,提高射频技术,联合c其他疗法等以提高疗效,并建立更合理的包括影像检查技术在内的疗效评价标准。

With the advent of continuous development of radiofrequency ablation（RFA）, this technique has been increasingly used in the treatment of renal cell carcinomas during recent years, with a significant therapeutic effect clinically. RFA is characteristic with the advantages of safety, convenience, minimal invasion, less complications and suffering. The improvement of the electrode needle, the radiofrequency techniques and the combination of other treatments are the key of the development of RFA in the near future. And more reasonable criteria for evaluating the therapeutic effects including imaging techniques are also needed to be set up.